Search all medical codes

Injection, aprepitant, 1 mg

HCPCS code

Name of the Procedure:

  • Common Name: Aprepitant Injection
  • Technical/Medical Term: Injection, aprepitant, 1 mg (HCPCS Code: J0185)

Summary

An aprepitant injection involves administering a dose of aprepitant, a medication that helps prevent nausea and vomiting caused by chemotherapy treatments. The medication is given through an intravenous (IV) line, allowing it to quickly enter the bloodstream.

Purpose

  • Medical Conditions/Problems: It is primarily used to prevent acute and delayed nausea and vomiting associated with chemotherapy.
  • Goals/Expected Outcomes: The goal is to reduce the incidence of chemotherapy-related nausea and vomiting, improving the patient's quality of life and allowing them to maintain their treatment regimen.

Indications

  • Specific Symptoms/Conditions: Patients undergoing chemotherapy treatments that are known to cause significant nausea and vomiting.
  • Patient Criteria: Typically indicated for patients who have a history of severe nausea and vomiting with chemotherapy or those undergoing highly emetogenic chemotherapy regimens.

Preparation

  • Pre-procedure Instructions: Patients may be advised to avoid eating for a few hours before the injection if sedation is used. They should inform their healthcare provider about any medications they are taking to avoid interactions.
  • Diagnostic Tests/Assessments: No specific tests are usually required, but a thorough medical history will be reviewed.

Procedure Description

  1. Step-by-Step Explanation: The healthcare provider will insert an intravenous (IV) line into a vein, usually in the patient's arm.
  2. Tools/Equipment/Technology: IV line, syringe containing aprepitant.
  3. Anesthesia/Sedation Details: Typically, no anesthesia or sedation is required, as it is a simple injection.

Duration

  • The procedure typically takes 5-10 minutes.

Setting

  • The injection is usually administered in an outpatient clinic, hospital, or chemotherapy center.

Personnel

  • Healthcare Professionals Involved: A nurse or a healthcare provider, under the supervision of a physician, usually administers the injection.

Risks and Complications

  • Common Risks: Mild pain or discomfort at the injection site, headache, fatigue.
  • Rare Risks: Allergic reactions, injection site reactions like redness or swelling.
  • Possible Complications: Management of any adverse reactions will depend on severity and may include medications or other interventions.

Benefits

  • Expected Benefits: Significant reduction or prevention of nausea and vomiting caused by chemotherapy.
  • Realization of Benefits: Benefits are generally noticed within a few hours post-injection and can last for several days.

Recovery

  • Post-Procedure Care/Instructions: Patients can usually resume normal activities immediately. Any unusual symptoms should be reported to a healthcare provider.
  • Expected Recovery Time: No downtime is required.
  • Restrictions/Follow-Up Appointments: Few restrictions; follow-up depends on the overall chemotherapy regimen.

Alternatives

  • Other Treatment Options: Oral antiemetics, other injectable antiemetics like ondansetron, natural remedies, and dietary adjustments.
  • Pros and Cons of Alternatives: Oral medications may be less invasive but could be less effective for some patients; other injectables may offer similar benefits, with varying side effects.

Patient Experience

  • During the Procedure: Patients might feel a slight pinch or discomfort when the needle is inserted.
  • After the Procedure: Most patients feel normal and can go about their day as usual. Pain can be managed with over-the-counter pain relief if necessary.

Medical Policies and Guidelines for Injection, aprepitant, 1 mg

Related policies from health plans

Similar Codes